After a period of intense expansion, when drugstore networks were competing with banks over rental space in city centres, lately there has been talk of relocating and closing shops. Plans made over the last few years have been upset, with a coherent strategy to be outlined as late as in the second half of the year, when the new pharmaceutical regulations on prices and margins will come into force. “The strategy will definitely be one of reshaping and consolidation of the existing business, which entails relocations and closures, but also openings of new drugstores. A relocation in fact entails 90% of what a new opening does. This process has started for some time for the big players and is likely to continue over the course of this year. However, I feel that many operators focus too much on cost cutting (renegotiating rent, making redundancies i.e.), which is understandable, and too little on business development projects and on rethinking their portfolio based on the new market trends (…),” says Dragos Dinu, partner of Link Resource, a consultancy specialised in the pharmaceutical industry.
ZF English
Drugstore chains in midst of relocations, closures and new investments
After a period of intense expansion, when drugstore networks were competing with banks over rental space in city centres, lately there has been talk of relocating and closing shops.